NCT00629720View on ClinicalTrials.gov

Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology

PHASE3CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Urinary Bladder Neurogenic
Interventions
DRUG

alfuzosin (SL770499)

Trial Locations (2)

19355

Sanofi-Aventis Administrative Office, Malvern

Unknown

Sanofi-Aventis Administrative Office, Belgrade

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00629720 - Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology | Biotech Hunter | Biotech Hunter